Sun allergy, also known as solar urticaria, is an uncommon, chronic and disabling form of physical urticaria (hives). Wheals accompanied by itching or burning sensation appear after a few minutes on sun-exposed skin, disappearing after 1 to 2 hours. In severe cases if the sun exposure is intense can lead to systemic symptoms or even anaphylaxis. Sun allergy is caused by eliciting wavelengths, commonly UV-A alone or with UV-B or visible light (VL).
Treatment options for sun allergy are antihistamines (i.e. Clartin, Zyrtec, Allegra, Benadryl), broadband sunscreens, phototherapy, IVIG, omalizumab (Xolair) or immunosuppressive treatments. In severe cases, combined treatments are insufficient.
Needless to say sun allergy (solar urticaria) can be completely debilitating to an individual, unless you live somewhere where there is minimal sun exposure. Since Xolair came out for chronic hives, Xolair for chronic hives, several physicians have been treating sun allergy patients with it. In the March 2016 issues of Annals of Allergy, Asthma and Immunology, a successful case of sun allergy was treated with Xolair.
Xolair (omalizumab) has only been recently introduced as a treatment for chronic or spontaneous urticaria (hives). To date 13 patients have received this treatment. Results have been variable, revealing a favorable response in about 9/13 (69.2%) patients. The average amount of time patients had the sun allergy was about 10 years. The wavelength most implicated in these patients were UV-A (38.4%), UV-A plus UV-B (15.3%) and UV-A plus VL (7.6%). The dosage of Xolair ranged from 400mg every 2 weeks to 150mg every 4 weeks. No severe side effects were described. The patients who had treatment failure were noted to be receiving low doses of Xolair (150mg every 4 weeks), it cannot be disregarded that an increase in the the treatment dose could be associated with better outcomes of the sun allergy.
Sun allergy (solar urticaria), can be very difficult to treat in patients as it is impossible to avoid the sun in most parts of the world. Xolair which is already approved for chronic urticaria (hives), may be a promising well tolerated effective agent in patients with sun allergy. More studies are needed to specify which patients can benefit most from this treatment.
If you suffer from solar urticaria, consult an allergy doctor or allergist who can help you navigate the best treatment options for you. Not every patient will be suitable for Xolair, but other combinations of medications may be able to treat this condition.
